News in the antifungal world: new drugs and resistance mechanisms
09 July 2021
6. Fungal infection & disease, 1-hour Oral Session
•
S103
•
13:15
>
14:15
•
News in the antifungal world: new drugs and resistance mechanisms
•
6. Fungal infections
13:15
•
2993
•
EUCAST ibrexafungerp (SCY-078) MICs for contemporary Danish yeast isolates
>
M.
Maiken Cavling
ARENDRUP (Copenhagen)
13:25
•
1046
•
Activity of manogepix, the active moiety of fosmanogepix against infrequently encountered yeast and mould isolates from the SENTRY antimicrobial surveillance programme (2017-2019)
>
M.
Michael D.
HUBAND (North Liberty)
13:35
•
2708
•
In-host acquisition of high-level amphotericin B resistance and identification of the first mechanism of clinical amphotericin B resistance in <em>Candida auris</em>
>
J.
Jeffrey
RYBAK (Memphis)
13:45
•
1362
•
<em>Candida parapsilosis</em> clinical azole cross-resistance acquisition is prompted by <em>MRR1</em> gain-of-function mutation
>
J.
Joana
BRANCO (Porto)
13:55
•
3138
•
Analysis of multiple resistance genes in <em>Candida glabrata</em> using targeted resequencing with multiplex long-range PCR
>
K.
Kathrin
SPETTEL (Vienna)
14:05
•
INT9
•
Q&A/Discussion
|